IMPACT OF ANEMIA ON LENGTH OF HOSPITAL STAY IN PATIENTS ADMITTED WITH HEART FAILURE
DOI:
https://doi.org/10.71000/v131dw74Keywords:
Anemia, Heart Failure, Hospitalization, Length of Stay, Morbidity, NYHA Classification, , Tertiary CareAbstract
Background: Anemia is a common comorbidity in heart failure and has been linked to poor outcomes, including increased mortality, reduced functional capacity, and higher hospitalization rates. However, its impact on the duration of hospital stay, particularly in resource-limited settings, remains underexplored.
Objective: To evaluate the impact of anemia on the length of hospital stay among patients admitted with heart failure in tertiary care hospital.
Methods: This cohort study was conducted over six months in the Department of Cardiology, Khyber Teaching Hospital, Peshawar. A total of 460 patients aged 40–80 years with diagnosed heart failure were enrolled using non-probability consecutive sampling. Patients were divided into two groups based on the presence or absence of anemia, defined as hemoglobin <13 g/dL in males and <12 g/dL in females. Data on demographics, clinical characteristics, NYHA class, hemoglobin levels, and hospital stay duration were collected. Statistical analysis was performed using SPSS v25, with significance set at p ≤ 0.05.
Results: Out of 460 patients, 230 had anemia and 230 did not. The anemic group had a longer mean hospital stay (4.83 ± 3.95 days) compared to the non-anemic group (3.76 ± 2.69 days), with the difference being statistically significant (p < 0.05). The anemic group also showed a higher proportion of NYHA Class III–IV status and lower mean hemoglobin levels (10.8 ± 1.1 g/dL vs. 13.9 ± 0.7 g/dL).
Conclusion: Anemia is associated with a significantly longer hospital stay in heart failure patients, highlighting the need for routine screening and management of anemia in this population to potentially reduce healthcare burden.
References
Chairat K, Rattanavipanon W, Tanyasaensook K, Chindavijak B, Chulavatnatol S, Nathisuwan S. Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand. Int J Cardiol Heart Vasc. 2020;30:100597.
Fukuoka R, Kohsaka S, Shiraishi Y, Sawano M, Abe T, Levy WC, et al. Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels. ESC Heart Fail. 2021;8(5):3917-28.
Habeeb HA, Todd F, Valsalan R, Schembri E, Noyhar JK, Yip G, et al. Prevalence and Adverse Outcomes of Iron Deficiency in Heart Failure. Curr Cardiol Rev. 2025;21(5):104-11.
Alharbi A, Shah M, Bansal N, Franz A, Kwak ES, Alsughayer A, et al. Outcomes and complications of heart failure with iron deficiency anemia: a nationwide analysis. Hosp Pract (1995). 2024;52(3):84-90.
Tee C, Xu H, Fu X, Cui D, Jafar TH, Bee YM. Longitudinal HbA1c trajectory modelling reveals the association of HbA1c and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus. PLoS One. 2023;18(1):e0275610.
Foust R, Clarkson S, Nordberg M, Joly J, Griffin R, May J. Iron Deficiency Among Hospitalized Patients With Congestive Heart Failure. J Healthc Qual. 2024;46(4):220-7.
Okita S, Saito Y, Yaginuma H, Asada K, Goto H, Hashimoto O, et al. Impact of the Stress Hyperglycemia Ratio on Heart Failure and Atherosclerotic Cardiovascular Events After Acute Myocardial Infarction. Circ J. 2025;89(3):340-6.
He Z, Zheng C, Chen M, Chen T, Huang F, Zhu Z, et al. Impact of the hemoglobin-to-red cell distribution width ratio on 30-day readmission in patients with heart failure. BMC Cardiovasc Disord. 2025;25(1):219.
Margineanu C, Antohi L, Ambrosy A, Bartos D, Collins S, Sinescu C, et al. Impact of iron deficiency on congestion and postdischarge survival in patients recently hospitalised for decompensated heart failure: a multicentre, prospective, observational analysis of the FERIC-RO study. Open Heart. 2025;12(1).
Okabe T, Yakushiji T, Kato D, Sato H, Matsuda T, Koyanagi Y, et al. Impact of Bicytopenia on Mortality in Hospitalised Patients With Heart Failure. Glob Heart. 2025;20(1):41.
Xu JP, Zeng RX, Mai XY, Pan WJ, Zhang YZ, Zhang MZ. How does HbA1c predict mortality and readmission in patients with heart failure? A protocol for systematic review and meta-analysis. Syst Rev. 2023;12(1):35.
Suenaga T, Fujino T, Hashimoto T, Ishikawa Y, Shinohara K, Matsushima S, et al. Hemoglobin Level Can Predict Heart Failure Hospitalization in Patients with Advanced Heart Failure Awaiting Heart Transplantation without Inotropes or Mechanical Circulatory Support. Int Heart J. 2024;65(4):667-75.
Hsiao FC, Lin CP, Hsu TJ, Tung YC, Chan YH, Chen SW, et al. Glycohemoglobin Variations and Long-term Risk of Incident Heart Failure in Patients With Type 2 Diabetes. Mayo Clin Proc. 2025;100(8):1332-44.
Schupp T, Weidner K, Reinhardt M, Abel N, Schmitt A, Lau F, et al. Effect of anaemia and iron deficiency in heart failure with mildly reduced ejection fraction. Eur J Clin Invest. 2024;54(8):e14205.
Chishiki T, Nagatomo Y, Saji M, Takei M, Goda A, Kohno T, et al. Divergent effect of blood glucose dysregulation on long-term clinical outcome in acute decompensated heart failure: A reappraisal in contemporary practice. Int J Cardiol. 2022;365:91-9.
Lejeune S, Roy C, Slimani A, Pasquet A, Vancraeynest D, Vanoverschelde JL, et al. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort. Cardiovasc Diabetol. 2021;20(1):48.
Kirzhner A, Green H, Koren R, Abu Khadija H, Sapojnik D, Schiller T. Diabetes and Acute Decompensated Heart Failure: A Comprehensive Analysis of In-Hospital Outcomes. Isr Med Assoc J. 2025;27(2):103-9.
Mistry RH, Kohut A, Ford P. Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes. Ann Hematol. 2021;100(3):661-6.
Chen S, Chen G, Jin Y, Zhu S, Jia L, Zhao C, et al. Association between glycated albumin and adverse outcomes in patients with heart failure. J Diabetes Investig. 2024;15(10):1457-63.
Sze S, Squire I, Kalra PR, Cleland JG, Petrie MC, Kalra PA, et al. Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial. Heart. 2025;111(13):634-41.
Cleland JGF, Pellicori P, Graham FJ, Lane R, Petrie MC, Ahmed F, et al. Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure. J Am Coll Cardiol. 2024;84(18):1704-17.
Sciaccaluga C, Mandoli GE, Nannelli C, Falciani F, Rizzo C, Sisti N, et al. Survival in acute heart failure in intensive cardiac care unit: a prospective study. Int J Cardiovasc Imaging. 2021;37(4):1245-53.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Arsh-E-Jabeen Nasir, Muhammad Faheem, Qinnat Ullah, Nazia Sultan, Abuzr Ali (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
